Sign up to save your podcasts
Or
Share How Roche Reduced Unnecessary Protocol Amendments to Impact Timeline and Cost
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
How Roche Reduced Unnecessary Protocol Amendments to Impact Timeline and Cost
About this podcast:
Liz Thompson, Global Development Leader, Senior Clinical Development Scientist at Roche, presented how the organization had delivered a single, cohesive protocol amendment categorization process to reduce the number of amendments and create a continuous improvement strategy, all to speed up timelines and reduce costs. This presentation comes from the September 2025 DPHARM: Disruptive Innovations to Modernize Clinical Research program.
More specifically, Ms Thompson discusses how Roche is:
For more information, go to DPHARMconference.com.
Liz Thompson, Global Development Leader, Senior Clinical Development Scientist at Roche, presented how the organization had delivered a single, cohesive protocol amendment categorization process to reduce the number of amendments and create a continuous improvement strategy, all to speed up timelines and reduce costs. This presentation comes from the September 2025 DPHARM: Disruptive Innovations to Modernize Clinical Research program.
More specifically, Ms Thompson discusses how Roche is:
- Leveraging historical amendment data to enable study teams to understand why protocols are being amended
- Utilizing a visual data science platform to generate insights from data to make better data-driven decisions
- Applying retrospective learning into current protocols to curb the need for amendments
- Building in business value
For more information, go to DPHARMconference.com.
View all episodes
By Conference ForumAbout this podcast:
Liz Thompson, Global Development Leader, Senior Clinical Development Scientist at Roche, presented how the organization had delivered a single, cohesive protocol amendment categorization process to reduce the number of amendments and create a continuous improvement strategy, all to speed up timelines and reduce costs. This presentation comes from the September 2025 DPHARM: Disruptive Innovations to Modernize Clinical Research program.
More specifically, Ms Thompson discusses how Roche is:
For more information, go to DPHARMconference.com.
Liz Thompson, Global Development Leader, Senior Clinical Development Scientist at Roche, presented how the organization had delivered a single, cohesive protocol amendment categorization process to reduce the number of amendments and create a continuous improvement strategy, all to speed up timelines and reduce costs. This presentation comes from the September 2025 DPHARM: Disruptive Innovations to Modernize Clinical Research program.
More specifically, Ms Thompson discusses how Roche is:
- Leveraging historical amendment data to enable study teams to understand why protocols are being amended
- Utilizing a visual data science platform to generate insights from data to make better data-driven decisions
- Applying retrospective learning into current protocols to curb the need for amendments
- Building in business value
For more information, go to DPHARMconference.com.